Clinical Trial: Efficacy and Safety of Chaigui Granules for Mild-to-Moderate Depression with Liver Stagnation and Spleen Deficiency Syndrome: A Randomized, Double-Blind, Dose-Escalating, Placebo-Controlled Multicenter Phase IIb Trial (China)

China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Chaigui Granules for Mild-to-Moderate Depression with Liver Stagnation and Spleen Deficiency Syndrome: A Randomized, Double-Blind, Dose-Escalating, Placebo-Controlled Multicenter Phase IIb Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131999

Registration Time: 2026/09/08

Type: Interventional study

Primary Sponsor: Second Xiangya Hospital of CSU

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341425

Published by HT Digital Content Services with permission from Health Daily Digest....